📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Clean Max to Early Redeem ₹499 Crore Listed NCDs Using IPO Proceeds
Clean Max Enviro Energy Solutions has announced the early redemption of 4,990 listed Non-Convertible Debentures (NCDs) totaling ₹499 crore, scheduled for April 2, 2026. The company is utilizing proceeds from its Initial Public Offer (IPO) to facilitate this prepayment, alongside ₹100 crore in unlisted NCDs and a ₹400 crore facility from Tata Capital. Major institutional holders including Allianz Global Investors and Nomura will receive the principal plus accrued interest. This move indicates a strategic deleveraging of the balance sheet following its public listing.
Key Highlights
Early redemption of 4,990 listed, zero-coupon NCDs with a face value of ₹10 lakh each, totaling ₹499 crore.
Redemption date is set for April 2, 2026, with the record date fixed as per regulatory norms.
Funding for the redemption is sourced from the company's IPO proceeds as part of its debt management strategy.
Additional prepayments include ₹100 crore in unlisted NCDs and a ₹400 crore facility with Tata Capital Limited.
Major debenture holders involved include Allianz Global Investors, Nomura Capital, and IL&FS Infrastructure Debt Fund.
💼 Action for Investors
Investors should view this as a positive step toward strengthening the balance sheet and reducing future interest costs. Monitor the company's post-IPO financial statements for improvements in the debt-to-equity ratio.
Gravita India to Acquire 98.95% Stake in Rashtriya Metal Industries for ₹559.08 Crores
Gravita India has signed definitive documents to acquire a 98.95% stake in Rashtriya Metal Industries Limited (RMIL) for a total cash consideration of ₹559.08 Crores. RMIL is a manufacturer of copper and copper alloy products with a strong turnover of ₹910 Crores in FY 2024-25. This acquisition is a strategic move to expand Gravita's presence in the copper segment and leverage RMIL's export network across the USA, UAE, and other regions. The transaction is expected to be completed by March 31, 2026.
Key Highlights
Acquisition of 41,08,639 equity shares representing ~98.95% of RMIL's paid-up capital.
Total cash consideration for the acquisition is ₹559.08 Crores.
RMIL reported a significant turnover growth from ₹598 Crores in FY23 to ₹910 Crores in FY25.
RMIL has a net worth of ₹300 Crores and total assets of ₹558 Crores as of March 31, 2025.
Target entity has a global footprint with exports to countries like USA, UAE, Thailand, and Saudi Arabia.
💼 Action for Investors
Investors should view this as a major growth catalyst that diversifies Gravita's portfolio into high-value copper products. Monitor the integration and its impact on consolidated margins in the coming fiscal years.
Landmark Cars Expands Hyderabad Network with New Mahindra & Mahindra Workshop
Landmark Cars is expanding its aftersales network in Hyderabad by opening a new Mahindra & Mahindra (M&M) workshop in Kompally. This facility, operated through its subsidiary Landmark Mobility Private Ltd, aims to address high demand at its existing two Hyderabad workshops. With this addition, the company will have 8 M&M outlets in Hyderabad and 12 across India. This move aligns with Landmark's strategy to deepen brand presence and leverage network effects in key geographies.
Key Highlights
Opening a new M&M workshop in Kompally, Hyderabad to meet high service demand.
Increases the total number of Mahindra & Mahindra outlets to 8 in Hyderabad.
Total Mahindra & Mahindra outlet count reaches 12 across the company's network.
The workshop will be managed by Landmark Mobility Private Ltd, a wholly owned subsidiary.
💼 Action for Investors
This expansion reinforces Landmark's strategy of deepening brand presence in high-growth regions and strengthening its high-margin aftersales segment. Investors should monitor the impact on service revenue and margins as the new facility scales.
Natural Capsules Subsidiary Signs ₹60 Cr Strategic CDMO Agreement with Fermbox Bio
Natural Biogenex, a material subsidiary of Natural Capsules Limited, has entered into a strategic framework agreement with Fermbox Bio to bolster fermentation-based CDMO capabilities. As part of the deal, Fermbox will provide equipment worth up to ₹60 crore at NBPL's Tumkur facility. This collaboration enables the company to target global biopharma and industrial biotech clients using advanced fermentation technology. The partnership is strategically timed to benefit from India's BioE3 Policy and the growing global demand for outsourced biomanufacturing.
Key Highlights
Natural Biogenex (NBPL) signs definitive agreements with Fermbox Bio for fermentation-based CDMO services.
Fermbox Bio to provide advanced equipment placement and technology worth up to ₹60 crore at NBPL’s Tumkur plant.
NBPL will handle GMP-compliant manufacturing, quality assurance, and regulatory compliance for the partnership.
The collaboration targets high-value segments in both pharmaceutical and industrial biotechnology.
The move aligns with the Indian government's BioE3 Policy to accelerate biomanufacturing innovation.
💼 Action for Investors
Investors should view this as a significant value-accretive step into high-margin CDMO services. Monitor the operationalization of the ₹60 crore equipment and the subsequent impact on the subsidiary's order book and margins.
IREDA Board to Meet on March 19 to Discuss Borrowing Plans for FY 2025-26 and FY 2026-27
IREDA has scheduled a board meeting on March 19, 2026, to discuss significant fundraising and borrowing strategies. The board will consider enhancing the borrowing plan for the current financial year 2025-26 and setting the market borrowing programme for FY 2026-27. These funds are expected to be raised through bonds, term loans, and commercial papers from both domestic and international markets. As per SEBI regulations, the trading window for the company's securities is closed with immediate effect until 48 hours after the meeting.
Key Highlights
Board meeting scheduled for March 19, 2026, to approve capital raising initiatives.
Proposal to enhance the existing borrowing plan for the current financial year 2025-26.
Discussion on the Market Borrowing Programme for FY 2026-27 involving domestic and international markets.
Fundraising instruments to include bonds, term loans, and Commercial Papers (CP).
Trading window for insiders closed immediately until 48 hours post-board meeting.
💼 Action for Investors
Investors should monitor the outcome of the March 19 meeting to understand the specific scale of the borrowing plan, which indicates the company's growth trajectory and lending capacity. The expansion of borrowing limits is generally a positive sign for a financing NBFC like IREDA.
Natural Capsules Subsidiary NBPL Signs Mfg Deal; Fermbox to Invest ₹60 Crore
Natural Biogenex Private Limited (NBPL), a material subsidiary of Natural Capsules Limited, has entered into a Framework and Contract Manufacturing agreement with Fermbox Bio Private Limited. Under this agreement, Fermbox will utilize the spare fermentation capacity of NBPL's plant. Significantly, Fermbox will invest up to ₹60 Crores in plant and machinery that will be owned by them but housed within NBPL's factory. This strategic move allows the company to monetize idle assets and leverage external capital for equipment, likely enhancing the subsidiary's operational throughput and revenue.
Key Highlights
Material subsidiary NBPL enters into a Framework & Contract Manufacturing agreement with Fermbox Bio.
Fermbox to invest up to ₹60 Crores in specialized plant and machinery at NBPL's facility.
The agreement aims to utilize the existing spare capacity of NBPL's fermentation plant.
Investment in machinery is funded by Fermbox while being integrated into NBPL's operational site.
The transaction is conducted at arm's length and does not involve related party interests.
💼 Action for Investors
Investors should monitor the execution timeline of the ₹60 Crore machinery installation and the resulting revenue growth in the subsidiary. This development is a positive indicator of better asset utilization and strategic partnership capabilities.
ACE Executes 50:50 Joint Venture Agreement with Japan's KATO WORKS
Action Construction Equipment (ACE) has formally executed an Investment and Shareholders Agreement with Japan-based KATO WORKS CO., LTD. to establish a 50:50 joint venture named ACE KATO Private Limited. The collaboration aims to integrate KATO's global technology and design expertise with ACE's robust manufacturing base and market reach in India. The agreement includes a 10-year lock-in period and equal board representation, with each party nominating two directors. This strategic move is expected to enhance product competitiveness and open new growth avenues in both domestic and international markets.
Key Highlights
Formation of a 50:50 Joint Venture between ACE and KATO WORKS CO., LTD., Japan.
Incorporation of 'ACE KATO Private Limited' with an initial paid-up capital of Rs. 5,00,000.
Mandatory 10-year lock-in period from the date of incorporation to ensure long-term stability.
Equal governance with each partner entitled to nominate 2 directors to the Board.
Strategic focus on leveraging Japanese technology to improve cost efficiency and product performance.
💼 Action for Investors
Investors should view this as a significant long-term positive that enhances ACE's technological capabilities and export potential. Monitor the joint venture's product development timeline and its eventual impact on the company's consolidated order book and margins.
Biocon Receives US FDA Approval for Liraglutide Injection (gVictoza)
Biocon Pharma Limited, a wholly-owned subsidiary of Biocon, has received US FDA approval for its Liraglutide Injection (gVictoza), 18 mg/3 mL. This product is indicated for the treatment of Type 2 Diabetes Mellitus in adults and children aged 10 and above. This approval follows the recent February 24, 2026, approval for gSaxenda, another Liraglutide variant. The move strengthens Biocon's portfolio of vertically integrated, complex drug products in the high-growth US market.
Key Highlights
Received US FDA approval for Liraglutide Injection (gVictoza) 18 mg/3 mL (6 mg/mL) prefilled pens.
Approval granted to Biocon Pharma Limited, a 100% subsidiary of Biocon Limited.
Follows a previous approval for Liraglutide injection (gSaxenda) received on February 24, 2026.
Targeted at the Type 2 Diabetes Mellitus market for patients aged 10 years and older.
Strengthens the company's position in vertically integrated, complex generic drug products.
💼 Action for Investors
Investors should monitor the commercial launch and market share gains in the US GLP-1 segment, as this approval enhances Biocon's high-margin complex generics pipeline. The stock may see positive momentum due to the expansion of its diabetes care portfolio.
Ambuja Cements Completes Sanghi Industries Merger; Sets Record Date for April 6, 2026
Ambuja Cements has announced that the merger of Sanghi Industries Limited into the company has become effective as of March 12, 2026. This follows the filing of the NCLT Ahmedabad Bench's sanction order with the Registrar of Companies. The appointed date for the scheme is retrospectively fixed as April 1, 2024. Shareholders of Sanghi Industries as of the record date, April 6, 2026, will be eligible for the allotment of Ambuja Cements' equity shares.
Key Highlights
Scheme of Arrangement between Sanghi Industries and Ambuja Cements became effective on March 12, 2026
Record date for share allotment to Sanghi Industries shareholders is fixed for April 6, 2026
The retrospective appointed date for the merger is April 1, 2024
Sanghi Industries stands dissolved without winding up following the successful amalgamation
Filing with the Registrar of Companies completed on March 12, 2026, satisfying all scheme conditions
💼 Action for Investors
Shareholders of Sanghi Industries should ensure they hold their positions until the record date of April 6, 2026, to receive Ambuja Cements shares. Ambuja Cements investors should view this as a positive capacity expansion move that strengthens its presence in Western India.
Ambuja Cements Completes Sanghi Industries Merger; Record Date Set for April 6, 2026
Ambuja Cements has announced that the Scheme of Arrangement for the merger of Sanghi Industries into itself became effective on March 12, 2026. Following the filing of the NCLT order, Sanghi Industries stands dissolved and its operations are integrated with Ambuja Cements with a retrospective appointed date of April 1, 2024. The company has fixed April 6, 2026, as the record date to determine the eligibility of Sanghi shareholders for the issuance of new Ambuja Cements shares. This merger is a significant step in Ambuja Cements' expansion strategy to strengthen its market position in Western India.
Key Highlights
Scheme of Arrangement between Sanghi Industries and Ambuja Cements became effective on March 12, 2026
Record Date for determining shareholders for share swap is fixed as Monday, April 6, 2026
The Appointed Date for the merger is April 1, 2024, as per the sanctioned scheme
Sanghi Industries stands dissolved without being wound up following the filing of the NCLT order
New equity shares of Ambuja Cements will be issued to Sanghi shareholders as per the defined Swap Ratio
💼 Action for Investors
Sanghi Industries shareholders should ensure their holdings are settled by the April 6 record date to receive Ambuja Cements shares. Ambuja Cements investors should track the integration for expected operational synergies and capacity growth.
Kalpataru Signs Andheri Redevelopment Project with ₹1,400 Crore GDV Potential
Kalpataru Limited has secured a prestigious redevelopment project for Shree Mahalakshmi CHS in Andheri West, Mumbai. The project covers approximately 3 acres of land and is estimated to have a Gross Development Value (GDV) of around ₹1,400 crore. With a potential carpet area of 0.4 million square feet, this residential development strengthens the company's project pipeline in the high-demand Mumbai Metropolitan Region. This move aligns with Kalpataru's strategy to focus on premium redevelopment opportunities in established micro-markets.
Key Highlights
Estimated Gross Development Value (GDV) of approximately ₹1,400 crore
Total potential carpet area of ~0.4 million square feet (msf) on a 3-acre land parcel
Located in the prime Andheri West micro-market with high connectivity and social infrastructure
Adds to the company's robust pipeline of 29 ongoing and planned projects totaling 41.2 MSF
💼 Action for Investors
Investors should monitor the project's approval and launch timelines as it represents a significant high-value addition to the company's portfolio. The project's location in a premium micro-market suggests healthy margin potential and strong absorption rates.
ACME Solar Commissions 33.335 MW Phase II of Rajasthan BESS Project
ACME Solar Holdings, through its wholly owned subsidiary ACME Sun Power Private Limited, has commissioned the second phase of its 300 MW Battery Energy Storage System (BESS) project in Rajasthan. This phase contributes 33.335 MW / 160.51 MWh to the total project, with the commercial operation date set for March 14, 2026. To date, the company has successfully commissioned a total of 66.67 MW / 320.99 MWh of the planned 300 MW capacity. This milestone reflects steady execution in the high-potential energy storage segment.
Key Highlights
Commissioned 33.335 MW / 160.51 MWh as part of Phase II of the Rajasthan BESS project
Total commissioned capacity for this specific project now stands at 66.67 MW / 320.99 MWh
Commercial Operation Date (COD) for the second phase is confirmed for March 14, 2026
The project is located at Village Badi Sid, Rajasthan, and is managed by a wholly owned subsidiary
💼 Action for Investors
Investors should view this as a positive step in the company's operational ramp-up and monitor the timeline for the remaining 233.33 MW capacity. Successful execution of BESS projects is critical for the company's long-term valuation in the renewable energy sector.
Ambuja Cements Completes Sanghi Industries Merger; Sets Record Date for Share Swap as April 6, 2026
Ambuja Cements has announced that the Scheme of Arrangement for the merger of Sanghi Industries into itself has become effective as of March 12, 2026. The company has fixed April 6, 2026, as the record date to determine eligible shareholders of Sanghi Industries for the issuance of new Ambuja Cements shares. This merger, with a retrospective appointed date of April 1, 2024, results in the dissolution of Sanghi Industries without winding up. The consolidation is expected to strengthen Ambuja's market position and provide operational synergies within the Adani Group's cement portfolio.
Key Highlights
Scheme of Arrangement became effective on March 12, 2026, following NCLT and ROC filings
Record Date fixed for April 6, 2026, to determine eligibility for the issuance of new equity shares
Appointed Date for the merger is set at April 1, 2024
Sanghi Industries stands dissolved without being wound up as a consequence of the merger
New equity shares of Ambuja Cements will be issued to Sanghi shareholders as per the defined swap ratio
💼 Action for Investors
Sanghi Industries shareholders should ensure their holdings are settled by the April 6 record date to receive Ambuja Cements shares. Ambuja Cements investors should watch for synergy benefits and capacity integration updates in upcoming quarterly reports.
Sanghi Industries Merges with Ambuja Cements; Sets April 6, 2026 as Record Date for Share Swap
Sanghi Industries has announced that its merger with Ambuja Cements Limited is now effective as of March 12, 2026, following the filing of the NCLT order. The company has fixed April 6, 2026, as the record date to determine shareholders eligible to receive new equity shares of Ambuja Cements as per the approved swap ratio. Consequently, Sanghi Industries will stand dissolved without winding up, and its existing equity shares will be cancelled. This marks the final step in the integration of Sanghi Industries into the Adani-owned Ambuja Cements.
Key Highlights
Scheme of Arrangement with Ambuja Cements became effective on March 12, 2026
Record Date for share swap and cancellation of Sanghi shares fixed for April 6, 2026
Appointed Date for the merger scheme is retrospectively set to April 1, 2024
Sanghi Industries will be dissolved without being wound up following the merger completion
💼 Action for Investors
Investors holding Sanghi Industries shares should ensure they are in their demat accounts by April 6, 2026, to receive Ambuja Cements shares. No further action is required as the share swap will occur automatically based on the scheme's ratio.
Sanghi Industries Merges with Ambuja Cements; Sets April 6, 2026, as Record Date
Sanghi Industries Limited has announced that its Scheme of Arrangement for merger with Ambuja Cements Limited has become effective as of March 12, 2026. The company has fixed April 6, 2026, as the Record Date to determine shareholders eligible for the issuance of new equity shares in Ambuja Cements. Consequently, Sanghi Industries stands dissolved without winding up, and its operations are now part of the transferee company. The appointed date for this amalgamation is retrospective, set at April 1, 2024.
Key Highlights
Merger with Ambuja Cements Limited became effective on March 12, 2026
Record date for share swap and cancellation of Sanghi shares fixed as April 6, 2026
The Appointed Date for the Scheme of Arrangement is April 1, 2024
Sanghi Industries stands dissolved without being wound up following NCLT approval
💼 Action for Investors
Investors holding Sanghi Industries shares on April 6, 2026, will receive shares of Ambuja Cements as per the approved swap ratio. No manual action is required if shares are held in demat form, as the transition will occur automatically.
CESC Incorporates Four New Renewable Energy Subsidiaries via Purvah Green Power
CESC Limited, through its 87.99% subsidiary Purvah Green Power Private Limited, has incorporated four new wholly-owned subsidiaries on March 12, 2026. The new entities—Purvah Navurja, Purvah Cleantech Power, Purvah Bikaner - V One Power, and Purvah Clean Energy—each have an initial paid-up capital of Rs. 1,00,000. These companies are specifically established to explore and develop opportunities within the renewable power sector. This move signals CESC's continued strategic push into green energy and long-term capacity expansion.
Key Highlights
Incorporation of four new wholly-owned subsidiaries under Purvah Green Power Private Limited.
Each new entity has an initial subscribed and paid-up capital of Rs. 1,00,000.
CESC holds an 87.99% stake in the parent subsidiary, Purvah Green Power.
All four companies are focused on the renewable power sector for future growth.
The entities were incorporated on March 12, 2026, as part of a strategic expansion.
💼 Action for Investors
Investors should view this as a positive indicator of CESC's commitment to the renewable energy transition. Monitor for future announcements regarding specific project wins or capital expenditure plans involving these new subsidiaries.
JK Lakshmi Cement to Acquire 77.96% Stake in NECEM Cements for ₹19 Crore
JK Lakshmi Cement has approved the acquisition of a 77.96% stake in NECEM Cements Ltd for a cash consideration of ₹19 crore plus the takeover of certain liabilities. This strategic acquisition provides the company with captive mining rights in Assam, including approximately 40 million tonnes of limestone reserves. The company plans to utilize the acquired land and reserves to set up a 0.95 million tonne clinkerisation and grinding unit. While NECEM is currently a small, loss-making entity with FY25 revenue of ₹1.56 crore, the deal is a key step toward JK Lakshmi's long-term goal of reaching 30 million tonnes capacity.
Key Highlights
Acquisition of 77.96% equity stake for ₹19 crore cash plus past liabilities
Secures ~40 million tonnes of limestone reserves and captive mining rights in Assam
Enables setup of 0.95 MTPA Clinkerisation and 0.95 MTPA Cement Grinding units
Target entity NECEM Cements reported FY25 revenue of ₹1.56 crore and a loss of ₹4.59 crore
Transaction is expected to be completed on or before March 31, 2026
💼 Action for Investors
Investors should view this as a positive long-term strategic move to establish a footprint in the North East and secure raw material reserves. Monitor the timeline for the commencement of the new 0.95 MTPA capacity and the total quantum of liabilities taken over.
Sical Logistics Allots 1.45 Crore Equity Shares via Rights Issue at Rs 64 Per Share
Sical Logistics Limited has successfully completed the allotment of 1,45,35,790 equity shares on a rights basis. The shares were issued at a price of Rs 64 per share, including a premium of Rs 54, following the board's approval on March 12, 2026. This issuance has increased the company's total paid-up equity share capital from 6,52,49,080 shares to 7,97,84,870 shares. The allotment was finalized in consultation with the registrar, Cameo Corporate Services Limited, and the National Stock Exchange.
Key Highlights
Allotment of 1,45,35,790 fully paid-up equity shares of face value Rs 10 each.
Issue price set at Rs 64 per share, representing a premium of Rs 54 per share.
Total paid-up share capital increased from Rs 65.25 crore to Rs 79.78 crore.
The allotment follows the rights issue process initiated in January 2026 and the letter of offer dated February 16, 2026.
💼 Action for Investors
Investors should account for the equity dilution resulting from the 22.3% increase in the total share count. Monitor the company's upcoming financial statements to see how the proceeds are utilized for operational growth or debt reduction.
DNAMEDIA CEO Chitresh Sehgal Resigns After 5-Year Tenure
Diligent Media Corporation Limited (DNAMEDIA) has announced the resignation of Mr. Chitresh Sehgal as Chief Executive Officer, effective March 12, 2026. Mr. Sehgal, who served as a Key Managerial Personnel (KMP), is leaving the company after nearly five years to pursue external career interests. The resignation was formally tendered on January 12, 2026, allowing for a transition period. The company has not yet announced a successor for the top leadership role.
Key Highlights
Mr. Chitresh Sehgal resigned as CEO and Key Managerial Personnel effective March 12, 2026.
The executive is departing after a tenure of nearly 5 years with the organization.
The resignation was submitted on January 12, 2026, providing a two-month notice period.
The stated reason for departure is to pursue career interests outside the company.
💼 Action for Investors
Investors should monitor the company's upcoming announcements regarding the appointment of a new CEO to ensure leadership stability. Watch for any potential shifts in strategic direction following this transition in senior management.
CareEdge Reaffirms Orient Ceratech's BBB+ Rating; 9MFY26 Revenue Grows 25% to ₹305 Cr
CareEdge Ratings has reaffirmed Orient Ceratech Limited's long-term rating at 'CARE BBB+; Stable' and short-term rating at 'CARE A2'. The company reported a strong 9MFY26 performance with total operating income of ₹305.36 crore, representing a 25% year-on-year growth. Financial health remains robust with a low gearing of 0.27x and a significantly improved interest coverage ratio of 8.10x. While operational efficiency is high due to captive mines, the company faces risks from high working capital intensity and its association with the Ashapura Group.
Key Highlights
Reaffirmed CARE BBB+; Stable rating for ₹65.12 crore long-term bank facilities and CARE A2 for short-term facilities.
9MFY26 revenue reached ₹305.36 crore with a PAT of ₹16.20 crore, already exceeding the full-year FY25 PAT of ₹9.93 crore.
Interest coverage ratio strengthened significantly to 8.10x in 9MFY26 compared to 4.26x in FY25.
Completed ₹50 crore capex for capacity expansion and acquisition of a Chamotte plant, which is expected to double one product line's capacity.
Overall gearing remains comfortable at 0.27x as of March 2025, though the working capital cycle remains elongated at 184 days.
💼 Action for Investors
The rating reaffirmation combined with strong 9-month financial growth suggests operational stability and improved profitability. Investors should monitor the successful ramp-up of the new capacity and any potential financial support provided to group entities.